Di seguito sono riportate le informazioni acquisite su ABBOTT LABORATORIES LIMITED, che non è ancora inclusa nel nostro perimetro di ricerca.

Per richiedere una valutazione di questa azienda e l'inserimento nel Ranking OpenCorporation o se hai dati ulteriori, diversi e più aggiornati di quanto pubblicato in questa scheda aziendale OpenCorporation, scrivi a info@opencorporation.org così che il nostro team possa tenerne conto.

Aggiornato il 31 marzo 2022

Descrizione attività
(disponibile solo in inglese)

Wholesale of pharmaceutical goods (NACE2 4646)

This company was established in 1937. It is engaged in the production and distribution of anaesthetic products to the armed forces during the war. It is a highly diversified healthcare company that discovers, develops, manufactures and markets products and services--from prevention and diagnosis to treatment and cure. Its registered head office is based in Maidenhead, United Kingdom.The company markets more than 70 percent of its products in 130 countries worldwide. Its principal businesses are global pharmaceuticals, medical nutrition and medical products, including diagnostics and cardiovascular devices. It is a leader in the field of anaesthesia, pain management, anti-infectives and HIV therapies. Its milestones in the United Kingdom include the introduction of several products namely: Erythrocin (erythromycin sterarate), Isoflurane, Survanta (beractant), Sevoflurane, Norvir (ritonavir), Synagis (palivizumab), Chirocaine (levobupivacaine), Reductil (sibutramine), Kaletra (lopinavir/ritonavir), Humira (adalimumab) and Zemplar IV (paricalcitol injection). Its products are distributed in Africa, Asia Pacific, Europe, Latin America/Caribbean, Middle East, North America, and South America. It has its headquarters in Maidenhead, Berkshire. Its manufacturing sites are located in Queenborough, Witney, and Dartford. Its mission is to develop breakthrough healthcare products that advance patient care for diseases with the greatest unmet medical need and to improve lives by providing cost-effective healthcare products and services. The company has one of the top ten pharmaceutical product pipelines in the world.

  • ABBOTT LABORATORIES LIMITED

  • United Kingdom of Great Britain and Northern Ireland (GB)
  • Tipo di azienda: Corporate
  • Impresa controllante: ABBOTT (UK) HOLDINGS LIMITED
  • Amministratore Delegato (CEO): Mr Michael Robert Kendall Clayton
  • Compenso Amministratore Delegato: N/D
  • Sito web: www.abbottlaboratories.co.uk

Parametri finanziari

Numero di dipendenti

N/D
562
533
553

Fatturato 1

N/D
431
332
303

EBIT 1

N/D
15
5
9

EBITDA 1

N/D
27
15
17

1 numeri espressi in milioni

  • RepRisk indicator (ultimo mese):  N/D

Dialogo sociale

  • Transnational Corporate Agreement (TCA): N/D
  • Global Framework Agreement (GFA): N/D
  • Societas Europaea (SE): N/D
  • Bangladesh Accord: N/D

Comitati Aziendali Europei

  • CAE: N/D

Standard e certificazioni

  • Global Compact: N/D
  • CDP (Carbon Disclosure Project): N/D
  • Modern Slavery Statement:
  • am.abbott.com/en-gb/documents/…
  • Transparency Index: N/D
  • SA8000 Social Accountability: N/D
  • Bilancio Integrato: N/D
  • ISO26000: N/D
  • Linee Guida Ocse:
  • Social Development Goals (SDGs): N/D

Certificazione Global Reporting Initiative

  • Global Reporting Initiative standards: N/D
  • Global Reporting Initiative GRI G4: N/D

Altre dichiarative aziendali

  • Responsabilità sociale d'impresa:
    N/D
  • Accessibilità: N/D

Policy

  • Policy sulla formazione: N/D
  • Policy a tutela del diritto alla salute e alla sicurezza nei luoghi di lavoro dove opera l'azienda: N/D
  • Policy a tutela del diritto alla salute e alla sicurezza nei luoghi di lavoro lungo filiera: N/D
  • Policy sulla diversità: N/D

Dichiarazioni universali

Dichiarazioni e trattati riconosciuti dal paese in cui l'azienda ha la sede legale

  • Dichiarazione universale dei Diritti Umani:
  • Convenzione europea dei diritti dell'uomo (CEDU):
  • Carta dei Diritti Fondamentali dei Lavoratori CDFL (Carta di Strasburgo 1989):
  • Carta dei diritti fondamentali dell'Unione Europea CDF UE (Carta di Nizza 2000):
  • Trattato sul funzionamento dell'Unione europea TFUE:
  • Sede legale in un Paese OCSE:
  • ILO C029 - Forced Labour Convention, 1930 (No. 29):
  • ILO C087 - Freedom of Association and Protection of the Right to Organise Convention, 1948 (No. 87):
  • ILO C098 - Right to Organise and Collective Bargaining Convention, 1949 (No. 98):
  • ILO C100 - Equal Remuneration Convention, 1951 (No. 100):
  • ILO C105 - Abolition of Forced Labour Convention, 1957 (No. 105):
  • ILO C111 - Discrimination (Employment and Occupation) Convention, 1958 (No. 111):
  • ILO C138 - Minimum Age Convention, 1973 (No. 138):
  • ILO C182 - Worst Forms of Child Labour Convention, 1999 (No. 182):

Direttive applicate alle sedi nella UE 27

  • D. 80/987/EEC:
  • D. 89/391/EEC:
  • D. 98/59/EC:
  • D. 2000/43/EC:
  • D. 2000/78/EC:
  • D. 2001/23/EC:
  • D. 2001/86/EC del Consiglio:
  • D. 2002/14/EC:
  • D. 2002/73/EC:
  • D. 2003/72/EC del Consiglio:
  • D. 2005/56/EC del PE e del Consiglio:
  • D. 2009/38/EC:
  • D. 2004/25/EC:
  • D. 2011/35/EU:

Presenza nei principali ranking

  • Global 100 Most Sustainable Corporations: N/D
  • Global CSR Rep Trak 100: N/D
  • BrandZ Top 100 Most Valuable US Brands: N/D
  • The Worlds Best Multinational Workplaces: N/D
  • The Gartner Supply Chain Top 25: N/D
  • The Worlds Most Innovative Companies: N/D
  • The Diversity Inc Top 50 Companies: N/D
  • Best Global Websites: N/D
  • Green Ranking Global Top 500: N/D
  • Green Ranking Global Top 100: N/D

Sindacati di riferimento